Risk Prediction Model for Iodinated Contrast Medium Extravasation
RPMICME
Development and Validation of a Risk Prediction Model for Iodinated Contrast Medium Extravasation in Patients Undergoing Contrast-enhanced Computed Tomography
2 other identifiers
observational
1,000
1 country
1
Brief Summary
This study aims to develop a risk prediction model for iodine contrast agent extravasation from peripheral veins and to implement this model clinically to establish a risk control management system for iodine contrast agent extravasation.A case-control study design was employed to collect data for model development. The case group comprised patients who experienced iodine contrast agent extravasation during enhanced CT examinations, while the control group included patients who underwent similar examinations without extravasation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2025
CompletedFirst Submitted
Initial submission to the registry
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
March 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
March 5, 2025
February 1, 2025
1.3 years
February 24, 2025
February 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
accuracy of prediction model
the ratio of correct predictions to the total number of model predictions(%)
through study completion, an average of 1 year
the incidence of peripheral venous iodine contrast agent extravasation
the number of iodine contrast agent extravasation times divided by the total number of enhanced CT examinations during the same period(%)
One year before and after the prediction model is put into use.
Eligibility Criteria
Patients who received enhanced CT scans via peripheral venous indwelling needle.
You may qualify if:
- Volunteer to participate in this study.
- Without contraindications such as iodine contrast allergy or hyperthyroidism. -
You may not qualify if:
- There are communication barriers between researchers and patients.
- Due to critical condition or unstable vital signs, patients should be transferred to relevant clinical departments for treatment or observation immediately after examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhang Wenyanlead
Study Sites (1)
TongjiHospital
Wuhan, Hubei, 430030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wenyan Zhang, Master
Tongji Hospital
Central Study Contacts
Qin Li
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
February 24, 2025
First Posted
March 5, 2025
Study Start
January 25, 2025
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
March 5, 2025
Record last verified: 2025-02